Intelligent Bio Solutions Inc. INBS
2.10 USD -0.15 (-6.67%)
At closeNov 11, 2026, 5:04 PM EST
2.05 -0.05 -2.38%
After hours · Nov 11, 5:04 PM ET
2.01 Day range 2.24
1.44 52-week range 17.92
- YTD
- -77.96%
- 1 year
- -73.98%
News
benzinga.com Intelligent Bio Solutions Q1 EPS $(0.86) Beats $(1.31) Estimate, Sales $1.392M Miss $1.400M Estimate Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(0.86) per share which beat the analyst consensus estimate of $(1.31) by 34.35 percent. This is a 75.43 percent increase over…
globenewswire.com Intelligent Bio Solutions Reports Record Fiscal First Quarter 2027 Revenue of $1.39 Million, Marking Sixth Consecutive Quarter of Year-Over-Year Growth Revenue up 25% year-over-year and 21% sequentially, marking third consecutive quarter above $1 million
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers MaxCyte (NASDAQ:MXCT) stock increased by 21.4% to $1.53 during Monday's pre-market session. The market value of their outstanding shares is at $130.0 million. Vir Biotechnology (NASDAQ:VIR)…
globenewswire.com Intelligent Bio Solutions to Present at the Webull Biotech Webinar on November 12 NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Curis (NASDAQ:CRIS) stock moved upwards by 83.5% to $1.31 during Wednesday's pre-market session. The company's market cap stands at $1.7 million. SCWorx (NASDAQ:WORX) stock increased by…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers SCWorx (NASDAQ:WORX) stock rose 47.8% to $3.96 during Tuesday's pre-market session. Integra Lifesciences (NASDAQ:IART) shares increased by 31.97% to $17.75. The market value of their…- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Flyte Aviation, Inc. Common Stock (AMEX:VJET) stock moved upwards by 34.0% to $2.17 during Monday's after-market session. Option Care Health (NASDAQ:OPCH) shares rose 20.92% to $28.26. The…
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Elutia (NASDAQ:ELUT) stock moved upwards by 17.2% to $0.94 during Thursday's after-market session. The market value of their outstanding shares is at $34.9 million. Intelligent Bio Solutions…
seekingalpha.com Intelligent Bio Solutions Inc. (INBS) Discusses FDA 510(k) Submission and Progress of Intelligent Fingerprinting Drug Screening System Transcript Intelligent Bio Solutions Inc. (INBS) Discusses FDA 510(k) Submission and Progress of Intelligent Fingerprinting Drug Screening System Transcript- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Greenland Mines (NASDAQ:GRML) stock rose 108.1% to $5.93 during Monday's pre-market session. The market value of their outstanding shares is at $9.0 million. Cue Biopharma (NASDAQ:CUE) stock…
benzinga.com Intelligent Bio Solutions Registers 6,211,809 Shares Of Common Stock For Resale Underlying Warrants INTELLIGENT BIO SOLUTIONS INC. 6,211,809 Shares of Common Stock Pursuant to this prospectus, the selling stockholders identified herein (the "Selling Stockholders") are offering on a resale basis an…
globenewswire.com Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET Management to discuss FDA 510(k) submission, clinical data, and commercial progress outside the U.S. Management to discuss FDA 510(k) submission, clinical data, and commercial progress outside the…
benzinga.com Intelligent Bio Submits Comprehensive Clinical Data to Enter US Drug Screening Market Intelligent Bio Solutions submitted a 510(k) notification to the FDA for its fingerprint drug screening system to enter the US market.
globenewswire.com Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing…- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Gelteq (NASDAQ:GELS) stock moved upwards by 20.3% to $0.84 during Wednesday's after-market session. The company's market cap stands at $5.6 million. Nyxoah (NASDAQ:NYXH) shares increased by…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session Gainers Intelligent Bio Solutions (NASDAQ:INBS) stock moved upwards by 8.2% to $2.63 during Tuesday's after-market session. The company's market cap stands at $7.2 million. Jaguar Health…
benzinga.com UPDATE: Intelligent Bio Solutions Commences ~$5M Placement Of Common Shares, Warrants At Combined Price Of $2.455 Per Share Intelligent Bio Solutions Inc. ("INBS" or the "Company") (NASDAQ:INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it has entered- benzinga.com Intelligent Bio Solutions Reports 98.2% Accuracy In Codeine Study, Accelerates FDA 510(k) Submission To September 2026 Intelligent Bio Solutions Inc. (NASDAQ:INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the results of its
benzinga.com Intelligent Bio Solutions Commences ~$M Placement Of Common Shares, Warrants At Combined Price Of $2.455 Per Share Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it has entered
globenewswire.com Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission Multi-site clinical study delivers strong performance data for Intelligent Fingerprinting Drug Screening System Multi-site clinical study delivers strong performance data for Intelligent…
globenewswire.com Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules $5 Million Upfront at Closing and $5 Million Tranche Warrant Callable by the Company Following FDA 510(k) Clearance of Intelligent Fingerprinting Drug Screening System $5 Million Upfront at Closing…- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers bioAffinity Technologies (NASDAQ:BIAF) shares increased by 68.4% to $7.68 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.7 million. Lakewood-Amedex…
defenseworld.net BlackRock Inc. Invests $149.96 Million in Intelligent Bio Solutions Inc. $INBS BlackRock Inc. purchased a new stake in shares of Intelligent Bio Solutions Inc. (NASDAQ: INBS) during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers ZeroStack (NASDAQ:ZSTK) stock increased by 440.2% to $9.94 during Wednesday's regular session. The company's market cap stands at $4.4 million. Tenon Medical (NASDAQ:TNON) shares moved…
globenewswire.com Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth Reader installed base grew 22% year-over-year, driving a 35% increase in total consumable cartridges to over 100,000 units
benzinga.com Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action? Shares of Intelligent Bio Solutions Inc. (NASDAQ:INBS) are surging Monday afternoon after the medical technology company announced a significant regulatory milestone for its rapid testing unit.
benzinga.com Intelligent Bio Solutions Shares Surge Monday: What's Driving the Action? Shares of Intelligent Bio Solutions are surging Monday after it announced a significant regulatory milestone for its rapid testing unit.- benzinga.com Intelligent Bio Solutions' Intelligent Fingerprinting Drug Screening Business Has Been ISO Recertified To The 13485:2016 Quality Management System Standard And Will Be Valid For Three Years The recertification, issued by the British Standards Institution (BSI), is effective October 14, 2026, and will be valid for three years. On February 2, 2026, the U.S. FDA's amended Quality…
globenewswire.com Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification Recertification aligns with the FDA's newly amended Quality Management System Regulation and supports the Company's regulatory strategy as it pursues FDA clearance Recertification aligns with the…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers BioVie (NASDAQ:BIVI) shares increased by 39.4% to $1.77 during Wednesday's regular session. The market value of their outstanding shares is at $9.5 million. Sionna Therapeutics (NASDAQ:SION)…
globenewswire.com Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing…
benzinga.com Intelligent Bio Solutions Completes Usability Study For Intelligent Fingerprinting Drug Screening System To Detect Opiate Codeine Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the completion of…
globenewswire.com Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing…
globenewswire.com Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Fingerprinting System NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing…- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers Replimune Group (NASDAQ:REPL) stock rose 96.1% to $10.61 during Friday's regular session. SCYNEXIS (NASDAQ:SCYX) stock moved upwards by 22.54% to $4.57. The market value of their outstanding…
defenseworld.net Comparing Eurofins Scient (OTCMKTS:ERFSF) & Intelligent Bio Solutions (NASDAQ:INBS) Intelligent Bio Solutions (NASDAQ: INBS - Get Free Report) and Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two…- benzinga.com Intelligent Bio Solutions Resolves All Cybersecurity, Software-Related Review Items For Its Upcoming FDA Submission Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it has…
globenewswire.com Intelligent Bio Solutions Achieves Key Milestone Ahead of Planned FDA 510(k) Submission, Advancing Toward Planned U.S. Market Entry Company has addressed final review items from penetration testing and finalized cybersecurity and software documentation- benzinga.com Intelligent Bio Solutions Completes Precision Testing For Its Intelligent Fingerprinting Drug Screening System To Detect Opiate Codeine Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the completion of
globenewswire.com Intelligent Bio Solutions Completes Precision Testing, Strengthening FDA 510(k) Submission Package Ahead of Planned Entry into Multi-Billion-Dollar U.S. Drug Screening Market Precision testing confirms reproducibility across more than 1,600 tests, three production runs, and three independent testing sites Precision testing confirms reproducibility across more than 1,600…
benzinga.com Intelligent Bio Solutions Starts Interference Study To Support FDA Submission For U.S. Market Clearance Of Its Intelligent Fingerprinting Drug Screening System For Codeine Detection The Company has again partnered with CenExel Clinical Research, Inc. to complete the clinical study. The Interference Study will assess how potentially interfering substances may impact the…
globenewswire.com Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry Interference Study designed to validate system specificity in the presence of potentially interfering substances commonly encountered in real-world settings
globenewswire.com Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18 NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing…
benzinga.com Intelligent Bio Solutions Initiates Multi-Site Method Comparison Study To Support FDA 510(k) Submission For US Market Clearance Of Intelligent Fingerprinting Drug Screening System For Opiate Codeine Study designed to validate accuracy and real-world workplace performance of the Intelligent Fingerprinting Drug Screening System Company expects to complete enrollment and data collection by the end…
globenewswire.com Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission Study designed to validate accuracy and real-world workplace performance of the Intelligent Fingerprinting Drug Screening System Company expects to complete enrollment and data collection by the end…
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Intelligent Bio Solutions Q3 EPS $(1.80) Up From $(4.40) YoY, Sales $1.060M Up From $728.867K YoY Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(1.80) per share. This is a 59.09 percent increase over losses of $(4.40) per share from the same period last year. The company…- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com Intelligent Bio Solution Launches Validation Study Targeting A Significant Reduction In The Time Required To Analyze Its Intelligent Fingerprinting Drug Screening System The study aims to improve the already rapid time-to-result of INBS's drug screening technology, which collects samples in under a minute and provides results within ten minutes at the point of…